All News about Acumen Pharmaceuticals Inc
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://www.investors.com/wp-content/uploads/2023/11/A1-112023-alzheimers-jkrause.jpg)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](/next-assets/images/schema-image-default.png)
Acumen Pharmaceuticals's Earnings Outlook
November 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Acumen Pharmaceuticals's Earnings: A Preview
August 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/740236/moonlake.jpg)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
Acumen Pharmaceuticals to Participate in the UBS Biopharma Conference
November 02, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/09/06/screenshot_2023-09-06_at_5.34.09_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/07/26/acumen_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://www.marketbeat.com/logos/articles/med_20230719085627_acumen-soars-on-alzheimers-study.jpg)
![](https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/18/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/18/image40.jpg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.